NCT04748393 (TEAM-VTE) is a clinical trial in Venous Thromboembolism, sponsored by Leiden University Medical Center.

Who is sponsoring NCT04748393?

NCT04748393 is sponsored by Leiden University Medical Center.

What condition does NCT04748393 study?

NCT04748393 studies Venous Thromboembolism.

Is NCT04748393 still recruiting?

NCT04748393 is currently terminated. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT04748393: TEAM-VTE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding

Terminated Last updated 10 February 2021

What this trial tests

trial in Venous Thromboembolism in 90 participants. Terminated before completion.

Timeline

1 September 2018

Primary endpoint
1 February 2021

1 February 2021

Quick facts

Lead sponsor	Leiden University Medical Center
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 September 2018
Primary completion	1 February 2021
Estimated completion	1 February 2021
Sites	7 locations across France, Netherlands, Austria, United Kingdom, Germany, Switzerland

Conditions studied

Venous Thromboembolism — all drugs for Venous Thromboembolism →

Sponsor

Leiden University Medical Center

Who can join

Adults 18 to 50, female only, with Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is an international, multicenter, academically sponsored, observational study, that focusses on fertile female patients with proven symptomatic deep vein thrombosis of the legs (DVT) or acute pulmonary embolism (PE). The incidence and severity of abnormal menstrual bleeding will be assessed for each menstrual period and correlated to quality of life. Causes of abnormal menstrual bleeding other than active anticoagulant treatment will be assessed. Treatment of abnormal menstrual bleeding (all within routine clinical care) will be evaluated for efficacy and safety.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism.
de Jong CMM, Blondon M, Ay C, Buchmuller A, et al · · 2022 · cited 30× · PMID 35925686 · DOI 10.1182/blood.2022017101

Verify or expand the search:

Other recruiting trials for Venous Thromboembolism

Currently open trials in the same condition.

NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
NCT06861088 — The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
NCT07140523 — A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA · Phase 2 · recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT06440694 — Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) · Phase 3 · recruiting

Other Leiden University Medical Center trials

Trials by the same sponsor.

NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04748393 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04748393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing